Sign in

CIK 0001625101 · Non-accelerated filer<br>Smaller reporting company

PULSE BIOSCIENCES, INC.

Sign in to watch
Ticker
PLSE
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
465696597
Phone
510-906-4600
Business address
3957 POINT EDEN WAY, HAYWARD, CA, 94545
Former names
Electroblate, Inc.
  1. 4 Open-market buy Director bought 116,656 shares at $9.54 ($1,112,898)
  2. 4 Open-market buy Director bought 74,852 shares at $9.19 ($687,890)
  3. 4 Open-market buy Director bought 82,813 shares at $9.06 ($750,286)
  4. 4 Open-market buy Director bought 66,021 shares at $9.34 ($616,636)
  5. 4 Open-market buy Director bought 27,000 shares at $10.38 ($280,260)
  6. 4 Open-market buy Director bought 45,600 shares at $9.07 ($413,592)
  7. 4 Open-market buy Director bought 152,944 shares at $9.06 ($1,385,673)
  8. 4 Open-market buy Director bought 218,600 shares at an average $9.38 ($2,049,784)
  9. 4 Open-market buy Director bought 124,397 shares at $8.98 ($1,117,085)
  10. 4 Open-market buy Director bought 20,241 shares at an average $6.10 ($123,470)
  11. 4 Open-market buy Chief Executive Officer bought 5,393 shares at an average $6.52 ($35,156)
  12. 4 Open-market buy Chief Strategy Officer bought 17,800 shares at an average $5.90 ($105,090)
  13. 4 Option exercise Director acquired 76,075 shares (option exercise)
  14. 4 Option exercise Director acquired 13,265 shares (option exercise)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Option exercise Director acquired 1,667 shares (option exercise)
  19. 4 Option exercise Director acquired 1,667 shares (option exercise)
  20. 4 Derivatives Options or other derivatives

Page 4 of 12 · 231 filings